Profound Medical (PROF) Return on Capital Employed (2019 - 2026)

Profound Medical has reported Return on Capital Employed for 8 years, with the latest figure at 4.94% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 5539.0% year-over-year to 4.94%; the trailing twelve-month figure through Mar 2026 stood at 4.94% (up 5539.0% YoY), and the FY2025 full-year result was 9.37%, up 5606.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 4.94%, up from 11.8% in the prior quarter.
• The five-year high for Return on Capital Employed was 0.78% in Q1 2022, with the low at 194.33% in Q2 2023.
• Average Return on Capital Employed over 5 years is 74.62%, with a median of 70.17% recorded in 2023.
• Peak annual rise in Return on Capital Employed reached 7357 bps in 2024, while the deepest fall reached 11368 bps in 2024.
• Tracing PROF's Return on Capital Employed over 5 years: stood at 53.48% in 2022, then tumbled by 31 bps to 70.17% in 2023, then gained by 5 bps to 66.79% in 2024, then soared by 82 bps to 11.8% in 2025, then soared by 58 bps to 4.94% in 2026.
• The last three Return on Capital Employed figures came in at 4.94% (Q1 2026), 11.8% (Q4 2025), and 117.15% (Q3 2025), per Business Quant data.

Peer Comparison